Revisión
Degludec, una nueva insulina basal de acción ultra-lenta para el tratamiento de la diabetes tipo 1 y 2: avances en investigación clínica
Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: Advances in clinical research
Manuel Muñoz Torres
UGC Endocrinología y Nutrición, Hospital Universitario San Cecilio, Granada, España
Leído
14557
Vecesse ha leído el artículo
1643
Total PDF
12914
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 52 | 5 | 57 |
| 2025 11 | 300 | 34 | 334 |
| 2025 10 | 260 | 15 | 275 |
| 2025 9 | 304 | 24 | 328 |
| 2025 8 | 158 | 17 | 175 |
| 2025 7 | 166 | 7 | 173 |
| 2025 6 | 179 | 9 | 188 |
| 2025 5 | 244 | 9 | 253 |
| 2025 4 | 306 | 13 | 319 |
| 2025 3 | 285 | 8 | 293 |
| 2025 2 | 266 | 6 | 272 |
| 2025 1 | 163 | 3 | 166 |
| 2024 12 | 271 | 10 | 281 |
| 2024 11 | 221 | 11 | 232 |
| 2024 10 | 241 | 13 | 254 |
| 2024 9 | 290 | 11 | 301 |
| 2024 8 | 158 | 14 | 172 |
| 2024 7 | 172 | 8 | 180 |
| 2024 6 | 157 | 8 | 165 |
| 2024 5 | 180 | 12 | 192 |
| 2024 4 | 171 | 9 | 180 |
| 2024 3 | 188 | 13 | 201 |
| 2024 2 | 242 | 16 | 258 |
| 2024 1 | 182 | 9 | 191 |
| 2023 12 | 154 | 13 | 167 |
| 2023 11 | 209 | 13 | 222 |
| 2023 10 | 247 | 15 | 262 |
| 2023 9 | 134 | 9 | 143 |
| 2023 8 | 159 | 7 | 166 |
| 2023 7 | 178 | 9 | 187 |
| 2023 6 | 177 | 16 | 193 |
| 2023 5 | 215 | 9 | 224 |
| 2023 4 | 138 | 13 | 151 |
| 2023 3 | 133 | 12 | 145 |
| 2023 2 | 70 | 11 | 81 |
| 2022 1 | 87 | 15 | 102 |
| 2022 12 | 76 | 10 | 86 |
| 2022 11 | 110 | 16 | 126 |
| 2022 10 | 68 | 21 | 89 |
| 2022 9 | 111 | 16 | 127 |
| 2022 8 | 67 | 17 | 84 |
| 2022 7 | 78 | 13 | 91 |
| 2022 6 | 85 | 19 | 104 |
| 2022 5 | 75 | 8 | 83 |
| 2022 4 | 105 | 15 | 120 |
| 2022 3 | 162 | 18 | 180 |
| 2022 2 | 143 | 7 | 150 |
| 2021 1 | 108 | 8 | 116 |
| 2021 12 | 108 | 26 | 134 |
| 2021 11 | 137 | 17 | 154 |
| 2021 10 | 99 | 24 | 123 |
| 2021 9 | 82 | 12 | 94 |
| 2021 8 | 52 | 12 | 64 |
| 2021 7 | 82 | 12 | 94 |
| 2021 6 | 58 | 13 | 71 |
| 2021 5 | 66 | 18 | 84 |
| 2021 4 | 196 | 54 | 250 |
| 2021 3 | 100 | 27 | 127 |
| 2021 2 | 87 | 15 | 102 |
| 2020 1 | 92 | 12 | 104 |
| 2020 12 | 95 | 22 | 117 |
| 2020 11 | 94 | 8 | 102 |
| 2020 10 | 48 | 11 | 59 |
| 2020 9 | 81 | 17 | 98 |
| 2020 8 | 50 | 5 | 55 |
| 2020 7 | 75 | 12 | 87 |
| 2020 6 | 65 | 8 | 73 |
| 2020 5 | 45 | 14 | 59 |
| 2020 4 | 158 | 8 | 166 |
| 2020 3 | 76 | 15 | 91 |
| 2020 2 | 73 | 14 | 87 |
| 2020 1 | 68 | 6 | 74 |
| 2019 12 | 79 | 18 | 97 |
| 2019 11 | 61 | 16 | 77 |
| 2019 10 | 91 | 12 | 103 |
| 2019 9 | 57 | 18 | 75 |
| 2019 8 | 50 | 9 | 59 |
| 2019 7 | 68 | 25 | 93 |
| 2019 6 | 123 | 22 | 145 |
| 2019 5 | 270 | 61 | 331 |
| 2019 4 | 124 | 28 | 152 |
| 2019 3 | 18 | 6 | 24 |
| 2019 2 | 43 | 8 | 51 |
| 2019 1 | 47 | 7 | 54 |
| 2018 12 | 30 | 9 | 39 |
| 2018 11 | 46 | 10 | 56 |
| 2018 10 | 80 | 7 | 87 |
| 2018 9 | 40 | 6 | 46 |
| 2018 8 | 36 | 1 | 37 |
| 2018 7 | 44 | 1 | 45 |
| 2018 6 | 30 | 6 | 36 |
| 2018 5 | 31 | 8 | 39 |
| 2018 4 | 27 | 15 | 42 |
| 2018 3 | 26 | 0 | 26 |
| 2018 2 | 21 | 3 | 24 |
| 2018 1 | 13 | 0 | 13 |
| 2017 12 | 16 | 2 | 18 |
| 2017 11 | 33 | 3 | 36 |
| 2017 10 | 33 | 3 | 36 |
| 2017 9 | 34 | 3 | 37 |
| 2017 8 | 44 | 13 | 57 |
| 2017 7 | 37 | 6 | 43 |
| 2017 6 | 45 | 9 | 54 |
| 2017 5 | 41 | 7 | 48 |
| 2017 4 | 28 | 6 | 34 |
| 2017 3 | 33 | 63 | 96 |
| 2017 2 | 35 | 6 | 41 |
| 2016 1 | 31 | 3 | 34 |
| 2016 12 | 27 | 9 | 36 |
| 2016 11 | 55 | 8 | 63 |
| 2016 10 | 91 | 17 | 108 |
| 2016 9 | 58 | 10 | 68 |
| 2016 8 | 65 | 4 | 69 |
| 2016 7 | 43 | 2 | 45 |
| 2016 6 | 49 | 18 | 67 |
| 2016 5 | 49 | 26 | 75 |
| 2016 4 | 44 | 21 | 65 |
| 2016 3 | 44 | 19 | 63 |
| 2016 2 | 44 | 26 | 70 |
| 2015 1 | 35 | 32 | 67 |
| 2015 12 | 30 | 13 | 43 |
| 2015 11 | 56 | 16 | 72 |
| 2015 10 | 0 | 2 | 2 |
| 2015 9 | 0 | 1 | 1 |
| 2015 6 | 1 | 0 | 1 |
| 2015 3 | 0 | 1 | 1 |
| 2014 12 | 1 | 1 | 2 |
| 2014 11 | 3 | 0 | 3 |
| 2014 9 | 1 | 0 | 1 |
| 2014 7 | 1 | 3 | 4 |
| 2014 6 | 1 | 2 | 3 |
| 2014 5 | 1 | 2 | 3 |
| 2014 4 | 2 | 6 | 8 |
| 2014 3 | 16 | 8 | 24 |
Mostrar todo
